QuickView for MYC;jsessionid=D40631F1092410AB2ABA503D9BDA95CF;jsessionid=24481B37E3EE0660CC48D46677C179DD;jsessionid=1533985870406616C8C2331B79422650;jsessionid=27DB0965BA5690156192E63A9E18561C;jsessionid=0454B9D47E6620B53ADA6E019D7338C2 (gene)

1. Survey of activation-induced genome architecture reveals a novel enhancer of Myc.
2. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target i…
3. MYC overexpression leads to increased chromatin interactions at super-enhancers and MYC binding site…
4. Therapeutic targeting of "undruggable" MYC.
5. Development and Characterization of Benzoselenazole Derivatives as Potent and Selective c-MYC Transc…

There were no clinical trials for MYC;jsessionid=D40631F1092410AB2ABA503D9BDA95CF;jsessionid=24481B37E3EE0660CC48D46677C179DD;jsessionid=1533985870406616C8C2331B79422650;jsessionid=27DB0965BA5690156192E63A9E18561C;jsessionid=0454B9D47E6620B53ADA6E019D7338C2